Your browser doesn't support javascript.
loading
Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
Su, Henry K; Wenig, Bruce M; Haser, Grace C; Rowe, Meghan E; Asa, Sylvia L; Baloch, Zubair; Du, Eugenie; Faquin, William C; Fellegara, Giovanni; Giordano, Thomas; Ghossein, Ronald; LiVolsi, Virginia A; Lloyd, Ricardo; Mete, Ozgur; Ozbek, Umut; Rosai, Juan; Suster, Saul; Thompson, Lester D; Turk, Andrew T; Urken, Mark L.
Afiliação
  • Su HK; 1 Department of Otolaryngology-Head and Neck Surgery, Thyroid, Head and Neck Cancer (THANC) Foundation , New York, New York.
  • Wenig BM; 2 Department of Pathology, Mount Sinai Beth Israel, New York, New York.
  • Haser GC; 1 Department of Otolaryngology-Head and Neck Surgery, Thyroid, Head and Neck Cancer (THANC) Foundation , New York, New York.
  • Rowe ME; 1 Department of Otolaryngology-Head and Neck Surgery, Thyroid, Head and Neck Cancer (THANC) Foundation , New York, New York.
  • Asa SL; 3 Department of Pathology, Laboratory Medicine Program, Toronto General Hospital , Toronto, Canada .
  • Baloch Z; 4 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania.
  • Du E; 5 Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center, Albert Einstein College of Medicine , Bronx, New York.
  • Faquin WC; 6 Department of Pathology, Massachusetts General Hospital , Boston, Massachusetts.
  • Fellegara G; 7 Centro Consulenze Anatomia Patologica Oncologica, Centro Diagnostico Italiano , Milan, Italy .
  • Giordano T; 8 Department of Pathology, University of Michigan Medical School , Ann Arbor, Michigan.
  • Ghossein R; 9 Department of Pathology, Memorial Sloan-Kettering Cancer Center , New York, New York.
  • LiVolsi VA; 4 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania.
  • Lloyd R; 10 Department of Pathology and Laboratory Medicine, University of Wisconsin , Madison, Wisconsin.
  • Mete O; 3 Department of Pathology, Laboratory Medicine Program, Toronto General Hospital , Toronto, Canada .
  • Ozbek U; 11 Population Health Science and Policy, Mount Sinai Hospital , New York, New York.
  • Rosai J; 7 Centro Consulenze Anatomia Patologica Oncologica, Centro Diagnostico Italiano , Milan, Italy .
  • Suster S; 12 Department of Pathology, Medical College of Wisconsin , Milwaukee, Wisconsin.
  • Thompson LD; 13 Department of Pathology, Woodland Hills Medical Center , Woodland Hills, California.
  • Turk AT; 14 Department of Pathology, New York-Presbyterian/Columbia , New York, New York.
  • Urken ML; 15 Department of Otolaryngology-Head and Neck Surgery , Mount Sinai Beth Israel , New York, New York.
Thyroid ; 26(4): 512-7, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26953223
ABSTRACT

BACKGROUND:

Extrathyroidal extension (ETE) is a significant prognostic factor in papillary thyroid carcinoma (PTC). Minimal extrathyroidal extension (mETE) is characterized by involvement of the sternothyroid muscle or perithyroid soft tissue, and is generally identified by light microscope examination. Patients with mETE, identified pathologically, are automatically upstaged to pT3. However, the prognostic implications of mETE have been a source of controversy in the literature. Moreover, there is also controversy surrounding the identification of mETE on pathological specimens. The objective of this study was to determine the level of agreement among expert pathologists in the identification of mETE in PTC cases.

METHODS:

Eleven expert pathologists from the United States, Italy, and Canada were asked to perform a review of 69 scanned slides of representative permanent sections of PTC specimens. Each slide was evaluated for the presence of mETE. The pathologists were also asked to list the criteria they use to identify mETE.

RESULTS:

The overall strength of agreement for identifying mETE was slight (κ = 0.14). Inter-pathologist agreement was best for perithyroidal skeletal muscle involvement (κ = 0.46, moderate agreement) and worst for invasion around thick-walled vascular structures (κ = 0.02, slight agreement). In addition, there was disagreement over the constellation of histologic features that are diagnostic for mETE, which affected overall agreement for diagnosing mETE.

CONCLUSIONS:

Overall agreement for the identification of mETE is poor. Disagreement is a result of both variation in individual pathologists' interpretations of specimens and disagreement on the histologic criteria for mETE. Thus, the utility of mETE in staging and treatment of PTC is brought into question. The lack of concordance may explain the apparent lack of agreement regarding the prognostic significance of this pathologic feature.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patologia / Neoplasias da Glândula Tireoide / Carcinoma / Carcinoma Papilar Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patologia / Neoplasias da Glândula Tireoide / Carcinoma / Carcinoma Papilar Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article